Sarepta (SRPT), Summit Therapeutics (SMMT) Enter Licensing Agreement for Utrophin Modulator Pipeline
Go back to Sarepta (SRPT), Summit Therapeutics (SMMT) Enter Licensing Agreement for Utrophin Modulator PipelineStratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 3.55 -0.04 (1.11%) | |||||
---|---|---|---|---|---|---|
Previous Close | $3.59 | 52 Week High | $19.75 | |||
Open | $3.52 | 52 Week Low | $4.26 | |||
Day High | $3.62 | P/E | N/A | |||
Day Low | $3.44 | EPS | $0.00 | |||
Volume | 1,407,270 |
SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 127.39 +3.14 (2.53%) | |||||
---|---|---|---|---|---|---|
Previous Close | $124.25 | 52 Week High | $63.73 | |||
Open | $123.00 | 52 Week Low | $8.00 | |||
Day High | $130.61 | P/E | N/A | |||
Day Low | $121.80 | EPS | $-5.69 | |||
Volume | 1,694,409 |
AyreTrade, Inc. (AMEX: SUMM) | Delayed: 0.06 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.06 | 52 Week High | $0.24 | |||
Open | $40.78 | 52 Week Low | $0.02 | |||
Day High | $0.06 | P/E | N/A | |||
Day Low | $0.06 | EPS | $0.00 | |||
Volume | 7,226,927 |